GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Net Margin %

Tci Gene (ROCO:6879) Net Margin % : 2.06% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Tci Gene's Net Income for the six months ended in Dec. 2023 was NT$3.8 Mil. Tci Gene's Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil. Therefore, Tci Gene's net margin for the quarter that ended in Dec. 2023 was 2.06%.

The historical rank and industry rank for Tci Gene's Net Margin % or its related term are showing as below:

ROCO:6879' s Net Margin % Range Over the Past 10 Years
Min: 3.5   Med: 18.53   Max: 30
Current: 3.5


ROCO:6879's Net Margin % is ranked better than
77.9% of 1018 companies
in the Biotechnology industry
Industry Median: -150.095 vs ROCO:6879: 3.50

Tci Gene Net Margin % Historical Data

The historical data trend for Tci Gene's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Net Margin % Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
30.00 18.53 21.39 17.01 3.50

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only 21.63 27.04 2.78 5.26 2.06

Competitive Comparison of Tci Gene's Net Margin %

For the Biotechnology subindustry, Tci Gene's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tci Gene's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tci Gene's Net Margin % falls into.



Tci Gene Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tci Gene's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=11.673/333.855
=3.50 %

Tci Gene's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=3.793/183.992
=2.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tci Gene  (ROCO:6879) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tci Gene Net Margin % Related Terms

Thank you for viewing the detailed overview of Tci Gene's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines